Moreover, survival analysis and Cox regression models demonstrated that high expression levels of LILRB2 and APE1, advanced TNM stage, and LNM were independent risk factors for poor prognosis in CRC patients. This evidence concerns the gene LILRB2 and colorectal carcinoma.